| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/30/1999 | DE19813048A1 Nucleic acids useful for identifying compounds capable of inducing pathogen resistance in plants |
| 09/30/1999 | CA2324648A1 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/30/1999 | CA2323760A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | CA2323605A1 Protein phosphatase-related molecules |
| 09/30/1999 | CA2322661A1 Phenol oxidizing enzyme enzymes |
| 09/29/1999 | EP0945515A2 Production of proteins using homologous recombination |
| 09/29/1999 | EP0945506A1 Novel peptide, novel dna, and novel antibody |
| 09/29/1999 | EP0945504A2 Materials and method for control of pests |
| 09/29/1999 | EP0945465A1 Antagonistic monoclonal antibodies to human CD40 |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945463A2 Process for the preparation of human leukocyte (alpha) interferon |
| 09/29/1999 | EP0944737A1 Representations of bimolecular interactions |
| 09/29/1999 | EP0944725A1 Phosphodiesterase 8a |
| 09/29/1999 | EP0944723A2 Mammalian chemokines |
| 09/29/1999 | EP0944722A2 Pituitary-tumor-transforming-genes, and related products |
| 09/29/1999 | EP0944651A2 Genes amplified in cancer cells |
| 09/29/1999 | EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/29/1999 | CN1230223A High-affinity interleukin-4 muteins |
| 09/29/1999 | CN1230222A PTX-sensitive G proteins, prodn. and use thereof |
| 09/29/1999 | CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies |
| 09/29/1999 | CN1230195A Treatment of immune disorders |
| 09/29/1999 | CN1230182A Process for producing cyclodepsipeptide compounds and novel cyclodepsipeptide |
| 09/29/1999 | CN1229853A Prepn. tech. for anti-hepatitis B transfer factor |
| 09/29/1999 | CN1229799A Gene engineering immune toxin of anti-carcinoma of bladder and its prodn. process |
| 09/28/1999 | US5959187 Expression of oxygen-binding proteins in plants |
| 09/28/1999 | US5959091 The present invention is directed to a plant-colonizing microorganism, which has been engineered to contain heterologous dna coding for a high molecular weight protein having insecticidal activity against lepidopterous larvae. |
| 09/28/1999 | US5959086 The present invention relates to proteins associated with acute pancreatitis and agents for the diagnosis of this disease. |
| 09/28/1999 | US5959084 Bispecific antibodies, methods of production and uses thereof |
| 09/28/1999 | US5959083 Tetravalent bispecific receptors, the preparation and use thereof |
| 09/28/1999 | US5959079 CREBA isoform |
| 09/28/1999 | US5959075 Testis-specific insulin homolog polypeptides |
| 09/28/1999 | US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein |
| 09/28/1999 | US5958732 Anticoagulants in snake venom |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/28/1999 | US5958730 Isolated nucleic acid compounds encoding ftsy, vectors and transformed host cells for expressing the encoded protein, which can be used for identifying compounds that bind or inhibit the protein when screening for novel antibiotics |
| 09/28/1999 | US5958727 Methods for modifying the production of a polypeptide |
| 09/28/1999 | US5958725 Human DP1 homolog |
| 09/28/1999 | US5958724 Process for producing heme proteins |
| 09/28/1999 | US5958723 DNA encoding prostaglandin receptor DP |
| 09/28/1999 | US5958722 Use of recombinant inhibitor from Erythrina caffra for purifying serine proteases |
| 09/28/1999 | US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 09/28/1999 | US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and |
| 09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
| 09/28/1999 | US5958708 The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy. |
| 09/28/1999 | US5958705 Cytoplasmic modulators of integrin regulation/signaling |
| 09/28/1999 | US5958425 Viral vaccines |
| 09/28/1999 | US5958424 Recombinant chicken anemia virus particle |
| 09/28/1999 | US5958415 Protein allergen of Derf II and composition |
| 09/28/1999 | US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression |
| 09/28/1999 | US5958405 Human protein tyrosine kinase |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | CA2088354C Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 09/28/1999 | CA2076678C Improved chimeric toxins |
| 09/28/1999 | CA2072095C Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 09/28/1999 | CA1340772C Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
| 09/26/1999 | CA2264260A1 Polynucleotide molecules encoding neospora proteins |
| 09/24/1999 | CA2249660A1 Novel compounds |
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047927A1 An equine neospora isolate and its uses |
| 09/23/1999 | WO1999047923A2 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 09/23/1999 | WO1999047683A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | WO1999047677A2 Polypeptides homologous to vegf and bmp1 |
| 09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
| 09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | WO1999047662A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047661A2 Production of biofilaments in transgenic animals |
| 09/23/1999 | WO1999047658A1 The cytokine family member ef-7 |
| 09/23/1999 | WO1999047656A2 Nucleic acid binding proteins |
| 09/23/1999 | WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 09/23/1999 | WO1999047649A2 Polymerase chimeras |
| 09/23/1999 | WO1999047639A2 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047562A1 Nephrin gene and protein |
| 09/23/1999 | WO1999047561A1 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 09/23/1999 | WO1999047553A2 Bacterial yeal family members as targets for antimicrobial drug design |
| 09/23/1999 | WO1999047551A1 Wf14573 or its salt, production thereof and use thereof |
| 09/23/1999 | WO1999047544A1 nrdF |
| 09/23/1999 | WO1999047540A1 95 human secreted proteins |
| 09/23/1999 | WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 09/23/1999 | WO1999047535A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 09/23/1999 | WO1999047147A1 nrdG |
| 09/23/1999 | WO1999041379A3 Members of the d52 gene family |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19802139C1 Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung A monoclonal antibody specific for activated coagulation factor VII and its use |
| 09/23/1999 | CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1999 | CA2323830A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 09/23/1999 | CA2323761A1 95 human secreted proteins |
| 09/23/1999 | CA2323725A1 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 09/23/1999 | CA2323724A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | CA2323494A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | CA2322795A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | CA2321091A1 An equine neospora isolate and its uses |